- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
The CLIC Virtual Tour is designed to give everyone involved with the CTSA Program, regardless of in what capacity, an overview of what CLIC provides and how to make it work for you. Think: a virtual ‘walk-through’ of new website resources, ways to communicate and guidance on how to access. It will be a multipart series, including live question and answer sessions. Videos will be released on the
Meeting Theme: Achieving Health Equity through the Science of Translation
NCATS Rapid Response Un-Meeting
Moving scientific discoveries into the “real world” effectively, efficiently, and safely are core principles of translational science. With the advent of big data analytics and data derived from multiple sources, it has become increasingly clear that utilizing data from real-world contexts opens another key layer of the translational science process.
The Genomic Information Commons (GIC) is an NCATS/NIH funded continuously updating, queryable, federated system enabling and promoting clinical and genomic research across eight pediatric hospitals. A GIC goal is to harmonize IT, regulatory and workflow components across sites for sharing genomic and phenotypic data (including EHR data on millions of patients), as well as biospecimen metadata on broadly consented cohorts.
At this potentially transformative moment, GIC sites seek innovative and collaborative ideas from across the CTSA Consortium
The Center for Leading Innovation and Collaboration (CLIC), the coordinating center for the NCATS CTSA Program, is hosting this Un-Meeting. This is an unconventional meeting, which lacks the rules and structure of a traditional conference, focuses on bringing together researchers, clinicians, policymakers, public health professionals, healthcare innovators, and opinion leaders to discuss and develop innovative and effective ideas regarding climate change in human health.
The link between C2H2 and translational science is not intuitive for all. Working backward from climate-related disease to
Over the last five years, CLIC has engaged stakeholders and partners across the consortium to amplify the research of CTSAs and communicate the impact of translational science. We have translated data into action by creating annual bi-directional metric reports, disseminating stories through the Insights to Inspire annual program, and developing actionable and sustainable resources, From Insights
What is the real-world impact of our network? That is a question the Clinical and Translational Science Awards Program has been trying to answer since its inception. Over the past four years, the Center for Leading Innovation and Collaboration has pitched in on that effort, knitting together several tried and trusted evaluation methods to develop a new Stakeholder-Engaged Research Impact
Telehealth is an emerging field. Prior to the pandemic, telehealth was shown in several chronic conditions to improve access, reduce hospitalization rates, and have lower costs to the patient than traditional in person visits. These interventions are adaptable and have the potential to impact healthcare in communities which are medically underserved and under-resourced. Telehealth has also been shown to reduce health disparities among African Americans, improve screenings of chronic conditions and improve access to mental health care in rural areas. During the COVID-19 pandemic there has been
Looking to encourage members of your hub to get involved on Twitter? Feel free to use and modify this deck, aimed at those who are new to the platform.
May 27, 11:00 AM - 3:00 PM Eastern Time. This NCATS “Rapid-Response” Un-Meeting will encourage discussions to identify activities that can be initiated and sustained in the interpandemic period to include when a significant public health emergency arises in the future, these community based environments can seamlessly participate in joint projects to address the threat. Other potential topics include identifying opportunities to build models of outreach to better include community hospitals for recruitment and enrollment into academic clinical trials, identifying ways to increase participant
In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19.
Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities.
Rapid development and deployment of diagnostic testing for COVID-19 has been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands.
Introduction: In March 2020 academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators.
Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team.
Introduction: The COVID-19 pandemic changed the clinical research landscape in America. The most urgent challenge has been to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. Methods: IRB Offices developed plans to rapidly review protocols related to the COVID-19 pandemic.
Introduction: The Coronavirus Disease 2019 (COVID-19) created major disruptions at academic centers and health care systems globally. Clinical and Translational Science Awards (CTSA) fund hubs supported by the National Center for Advancing Translational Sciences which provide infrastructure and leadership for clinical and translational research at many such institutions.
Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention.
The 2020 COVID-19 pandemic has had a profound impact on the clinical research enterprises at the 60 Clinical and Translational Science Award (CTSA) Hubs throughout the nation.
The recipients of NIH Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research.
Clinical and Translational Science Award (CTSA) TL1 trainees and KL2 scholars were surveyed to determine the immediate impact of the COVID-19 pandemic on training and career development. The most negative impact was lack of access to research facilities, clinics, and human subjects, plus for KL2 scholars lack of access to team members and need for homeschooling.
Although the science of team science is no longer a new field, the measurement of team science and its standardization remain in relatively early stages of development. To describe the current state of team science assessment, we conducted an integrative review of measures of research collaboration quality and outcomes.
In order to conduct translational science, scientists must combine domain-specific expertise with knowledge on how to identify and cross translational hurdles, and insights on positioning discoveries for the next translational stage.
This message board is available to all in the Well-Being Integration Working Group on the CLIC website. Posts and replies are only visible to the Well-Being Integration Working Group.
Notifications:
A primary barrier to translation of clinical research discoveries into care delivery and population health is the lack of sustainable infrastructure bringing researchers, policymakers, practitioners, and communities together to reduce silos in knowledge and action.